Armata Pharmaceuticals Inc

ASE:ARMP  
1.87
-0.05 (-2.60%)
Earnings Announcements

Armata Pharmaceuticals Announces Third Quarter 2022 Results

Published: 11/09/2022 21:24 GMT
Armata Pharmaceuticals Inc (ARMP) - Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update.
Armata Pharmaceuticals Inc - Qtrly Net Loss per Share, Basic and Diluted $0.24.
Revenue is expected to be $1.67 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $2.3 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.